Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options.

Cancer Manag Res · 2020 · PMC7602897 · PMID 33149670

Europe PMC DOI

hedged sentences

0.2086

closest p · 4.2× alpha

0.2086

boldest claim

The sentences

a favorable trendP=0.2086not close (p > 0.1)

Although not statistically significant, a favorable trend towards an improved OS (HR 0.88; 95% CI 0.72–1.07; P=0.2086) and ORR (32.8% vs 26.7%; P=0.1201) was observed.

also in 1,335 other papers

a strong trendno p-value reported

OS data were not mature, however, there was a strong trend towards an improved OS in the pyrotinib arm (HR 0.46; 95% CI 0.22–0.99).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.